2026년 실제 재무 비교
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 대 Mizuho Financial Group, Inc. Sponosred ADR (Japan) 재무 비교
바로 답
4개 공통 지표를 같은 JPY 기준으로 비교합니다.
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)의 매출은 4,777,450,268,000 JPY입니다.
Mizuho Financial Group, Inc. Sponosred ADR (Japan)의 같은 지표는 9,490,330,969,000 JPY입니다.
Alpha Vantage의 같은 회계연도 자료를 사용했습니다.
핵심 정보
- Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 매출
- 4,777,450,268,000 JPY
- Mizuho Financial Group, Inc. Sponosred ADR (Japan) 매출
- 9,490,330,969,000 JPY
- Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 영업이익
- 573,042,315,000 JPY
- Mizuho Financial Group, Inc. Sponosred ADR (Japan) 영업이익
- 1,720,121,514,000 JPY
- Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 순이익
- 203,326,753,000 JPY
- Mizuho Financial Group, Inc. Sponosred ADR (Japan) 순이익
- 1,323,934,306,000 JPY
- Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 영업현금흐름
- 1,041,431,000,000 JPY
- Mizuho Financial Group, Inc. Sponosred ADR (Japan) 영업현금흐름
- 590,243,689,000 JPY